Skip to main content

Table 3 Prediction of mortality without RRT (Females)

From: BMI and its association with death and the initiation of renal replacement therapy (RRT) in a cohort of patients with chronic kidney disease (CKD)

Variables

HRs

95% CI

 

p

BMI categories

 Normal BMI

Reference group

   

 Overweight

0.96

0.62

1.50

0.864

 Mild obesity

0.94

0.59

1.49

0.792

 Moderate obesity+

0.96

0.60

1.53

0.865

 Age > =68 years

2.00

1.37

2.93

< 0.001

CKD stage

 Stage 1

Reference group

   

 Stage 2

3.89

0.48

31.63

0.204

 Stage 3A

3.85

0.48

30.86

0.205

 Stage 3B

5.10

0.68

38.17

0.113

 Stage 4

8.45

1.14

62.72

0.037

 Stage 5

9.93

1.31

75.45

0.027

Primary renal diagnoses

 Glomerulonephritis

Reference group

   

 Genetic renal disease

0.35

0.08

1.59

0.175

 Diabetic nephropathy

0.90

0.43

1.86

0.769

 Renovascular disease

0.67

0.34

1.34

0.263

 Cancer

1.76

1.25

2.46

0.001

 Diabetes

1.53

1.02

2.29

0.042

 PVD

1.46

0.94

2.26

0.093

 Chronic lung disease

1.35

0.95

1.92

0.096

 CAD

1.40

0.98

2.00

0.068

 All other CVD

1.54

1.09

2.18

0.015

IRSD quintiles

 Lowest

Reference group

   

 Low

0.86

0.52

1.40

0.534

 Middle

0.81

0.52

1.25

0.338

 High

0.88

0.56

1.37

0.572

 Highest

0.76

0.42

1.37

0.369

Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us